CREB3L1 as a potential biomarker predicting response of triple negative breast cancer to doxorubicin-based chemotherapy

Overview of attention for article published in BMC Cancer, August 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (52nd percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

So far, Altmetric has seen 6 tweets from 5 users, with an upper bound of 39,313 followers.

RT @JacksonImmunoR: CREB3L1 as a potential biomarker predicting response of triple negative breast cancer to doxorubicin-based chemotherapy…

CREB3L1 as a potential biomarker predicting response of triple negative breast cancer to doxorubicin-based chemotherapy #cancerresearch #breastcancer #JIRSecondaryAntibodies #openaccess https://t.co/Ya5EYPe9MH

RT @BMC_series: #BMCCancer recently published an article on a potential biomarker in triple negative #breastcancer that indicates a positiv…

RT @YanPengB553S: Collaboration of UTSW Pathology and Molecular Genetic Department on a potential predictive biomarker for triple negative…

This page shows the most recent tweets that mention this research output.

Click here to find out how to access more activity, including 2 additional tweets.